Log in to save to my catalogue

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6546468

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

About this item

Full title

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2019-06, Vol.129 (6), p.2210-2221

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Chimeric antigen receptor (CAR) T cells are a promising therapy for hematologic malignancies. B-cell maturation antigen (BCMA) is a rational target in multiple myeloma (MM).
We conducted a phase I study of autologous T cells lentivirally-transduced with a fully-human, BCMA-specific CAR containing CD3ζ and 4-1BB signaling domains (CART-BCMA), in...

Alternative Titles

Full title

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6546468

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6546468

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI126397

How to access this item